GLP-1 receptor agonist attenuates endoplasmic reticulum stress-mediated β-cell damage in Akita mice
Shunsuke Yamane, Yoshiyuki Hamamoto, Shin-Ichi Harashima, Norio Harada, Akihiro Hamasaki, Kentaro Toyoda, Kazuyo Fujita, Erina Joo, Yutaka Seino, Nobuya Inagaki, Shunsuke Yamane, Yoshiyuki Hamamoto, Shin-Ichi Harashima, Norio Harada, Akihiro Hamasaki, Kentaro Toyoda, Kazuyo Fujita, Erina Joo, Yutaka Seino, Nobuya Inagaki
Abstract
Aims/Introduction: Endoplasmic reticulum (ER) stress is one of the contributing factors in the development of type 2 diabetes. To investigate the cytoprotective effect of glucagon-like peptide 1 receptor (GLP-1R) signaling in vivo, we examined the action of exendin-4 (Ex-4), a potent GLP-1R agonist, on β-cell apoptosis in Akita mice, an animal model of ER stress-mediated diabetes.
Materials and methods: Ex-4, phosphate-buffered saline (PBS) or phlorizin were injected intraperitoneally twice a day from 3 to 5 weeks-of-age. We evaluated the changes in blood glucose levels, bodyweights, and pancreatic insulin-positive area and number of islets. The effect of Ex-4 on the numbers of C/EBP-homologous protein (CHOP)-, TdT-mediated dUTP-biotin nick-end labeling (TUNEL)- or proliferating cell nuclear antigen-positive β-cells were also evaluated.
Results: Ex-4 significantly reduced blood glucose levels and increased both the insulin-positive area and the number of islets compared with PBS-treated mice. In contrast, there was no significant difference in the insulin-positive area between PBS-treated mice and phlorizin-treated mice, in which blood glucose levels were controlled similarly to those in Ex-4-treated mice. Furthermore, treatment of Akita mice with Ex-4 resulted in a significant decrease in the number of CHOP-positive β-cells and TUNEL-positive β-cells, and in CHOP mRNA levels in β-cells, but there was no significant difference between the PBS-treated group and the phlorizin-treated group. Proliferating cell nuclear antigen staining showed no significant difference among the three groups in proliferation of β-cells.
Conclusions: These data suggest that Ex-4 treatment can attenuate ER stress-mediated β-cell damage, mainly through a reduction of apoptotic cell death that is independent of lowered blood glucose levels. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2010.00075.x, 2010).
Keywords: Apoptosis; Endoplasmic reticulum stress; Glucagon‐like peptide‐1.
Figures
References
- Oyadomari S, Araki E, Mori M. Endoplasmic reticulum stress‐mediated apoptosis in pancreatic β‐cells. Apoptosis 2002; 7: 335–345
- Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 1999; 13: 1211–1233
- Mori K. Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 2000; 101: 451–454
- Kaufman RJ, Scheuner D, Schroder M, et al. The unfolded protein response in nutrient sensing and differentiation. Nat Rev Mol Cell Biol 2002; 3: 411–421
- Friedrichsen BN, Neubauer N, Lee YC, et al. Stimulation of pancreatic β‐cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J Endocrinol 2006; 188: 481–492
- Miettinen P, Ormio P, Hakonen E, et al. EGF receptor in pancreatic β‐cell mass regulation. Biochem Soc Trans 2008; 36: 280–285
- Jin T, Liu L. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus. Mol Endocrinol 2008; 22: 2383–2392
- Zhou J, Pineyro MA, Wang X, et al. Exendin‐4 differentiation of a human pancreatic duct cell line into endocrine cells: involvement of PDX‐1 and HNF3β transcription factors. J Cell Physiol 2002; 192: 304–314
- Wang Q, Brubaker PL. Glucagon‐like peptide‐1 treatment delays the onset of diabetes in 8 week‐old db/db mice. Diabetologia 2002; 45: 1263–1273
- Farilla L, Bulotta A, Hirshberg B, et al. Glucagon‐like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 2003; 144: 5149–5158
- Jhala US, Canettieri G, Screaton RA, et al. cAMP promotes pancreatic β‐cell survival via CREB‐mediated induction of IRS2. Genes Dev 2003; 17: 1575–1580
- Li Y, Hansotia T, Yusta B, et al. Glucagon‐like peptide‐1 receptor signaling modulates β cell apoptosis. J Biol Chem 2003; 278: 471–478
- Buteau J, El Assaad W, Rhodes CJ, et al. Glucagon‐like peptide‐1 prevents beta cell glucolipotoxicity. Diabetologia 2004; 47: 806–815
- Bregenholt S, Moldrup A, Blume N, et al. The long‐acting glucagon‐like peptide‐1 analogue, liraglutide, inhibits β‐cell apoptosis in vitro. Biochem Biophys Res Commun 2005; 330: 577–584
- Park S, Dong X, Fisher TL, et al. Exendin‐4 uses Irs2 signaling to mediate pancreatic β cell growth and function. J Biol Chem 2006; 281: 1159–1168
- Toyoda K, Okitsu T, Yamane S, et al. GLP‐1 receptor signaling protects pancreatic beta cells in intraportal islet transplant by inhibiting apoptosis. Biochem Biophys Res Commun 2008; 367: 793–798
- Yoshioka M, Kayo T, Ikeda T, et al. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early‐onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 1997; 46: 887–894
- Oyadomari S, Koizumi A, Takeda K, et al. Targeted disruption of the Chop gene delays endoplasmic reticulum stress‐mediated diabetes. J Clin Invest 2002; 109: 525–532
- Harada N, Yamada Y, Tsukiyama K, et al. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic β‐cells in obese mice. Am J Physiol Endocrinol Metab 2008; 294: E61–E68
- Yusta B, Baggio LL, Estall JL, et al. GLP‐1 receptor activation improves β cell function and survival following induction of endoplasmic reticulum stress. Cell Metab 2006; 4: 391–406
- Wang J, Takeuchi T, Tanaka S, et al. A mutation in the insulin 2 gene induces diabetes with severe pancreatic β‐cell dysfunction in the Mody mouse. J Clin Invest 1999; 103: 27–37
- Stoy J, Edghill EL, Flanagan SE, et al. Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci USA 2007; 104: 15040–15044
- Tsunekawa S, Yamamoto N, Tsukamoto K, et al. Protection of pancreatic β‐cells by exendin‐4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies. J Endocrinol 2007; 193: 65–74
- Cunha DA, Ladriere L, Ortis F, et al. Glucagon‐like peptide‐1 agonists protect pancreatic β‐cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB. Diabetes 2009; 58: 2851–2862
- Butler AE, Janson J, Bonner‐Weir S, et al. β‐cell deficit and increased β‐cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52: 102–110
- Kendall DM, Riddle MC, Rosenstock J, et al. Effects of exenatide (exendin‐4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care 2005; 28: 1083–1091
Source: PubMed